TS

Tanisha Singh

Active Director Director DIN 11201991
DIN 11201991 First appointment Jul 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value •••• Premium profile

About Tanisha Singh

Data last updated:

Tanisha Singh is a Director at Nevro Medical Private Limited (since 2025). The company operates in Healthcare. Nevro Medical Private Limited reported revenue of ₹21.43 Cr (FY 2025).

DIN 11201991
Primary Designation Director
Industry Healthcare
First Appointment 18 Jul 2025
Oldest Company Age 3 yrs
Largest company Nevro Medical Private Limited · ₹21.43 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nevro Medical Private Limited U52311RJ2022PTC084487
Director18 Jul 20252022₹21.43 Cr (FY 2025)Active

Board colleagues of Tanisha Singh

NameDINCompanyDesignation
Juhi Singh09433999Nevro Medical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nevro Medical Private Limited
Premium access

Shareholding and investment profile for Tanisha Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tanisha Singh

Tanisha Singh currently holds 1 directorship: Nevro Medical Private Limited (Director, since 18 Jul 2025, revenue ₹21.43 Cr (FY 2025)).

Tanisha Singh was first appointed on 18 Jul 2025 as Director at Nevro Medical Private Limited.

The current boards of Tanisha Singh's companies include Juhi Singh (Nevro Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available